Why Can’t We Grow Things as Cheaply as Nature Does?

Cells now make a hundred times more antibody per litre than in the 1980s. The litre did not get cheaper at the same rate: sterile steel, oxygen transfer, heat removal, and purification now set the cost of growing things in a tank.

Last updated September 2026
Figure 1

A hundredfold more product per litre. The litre is still expensive.

Grams of therapeutic antibody per litre of mammalian cell culture at harvest: typical commercial fed-batch processes, and the best reported in development.

Antibody titer in mammalian cell culture, mid-1980s to 2025On a logarithmic scale, typical commercial antibody titers rose from roughly 0.05 grams per litre in the mid-1980s to 1–2 g/L around 1999, more than 5 g/L by 2017, and more than 8 g/L from 2024. The best reported development process reached 13 g/L in 2010.0.020.050.10.20.51251020198519901995200020052010201520202025Grams of product per litre (log scale)Mid-1980s mammalian culture: ~0.05 g/LLarge-scale antibody plants: 1–2 g/LRoutine 14-day fed-batch: >5 g/L2020–2023: 5–8 g/L2024 onward: >8 g/LTypical >8 g/LChemically defined fed-batch, 18 days: 13 g/LBest 13 g/L
2024 onward · 2024

>8 g/L · Production culture titers now surpassing 8 g/L (mAbs, 2024). Intensified and perfusion processes report more per litre, but at higher media and equipment cost per batch.

Figure 1: The typical series plots midpoints of ranges reported in industry reviews (Wurm 2004; Shukla and colleagues 2017; mAbs 2024) and should be read as the shape of the curve, not as audited plant data. The mid-1980s value is Derived from Wurm's hundredfold comparison and is approximate. The 2010 point is Measured in a development process (Huang and colleagues) and is not a commercial average. Titer is harvest concentration only; purification losses come later. Select any point for its source.
>100×Rise in harvest titer since the mid-1980s, mostly from better media, feeding, and process control rather than bigger tanks.
$10s–100sCost of goods per gram of antibody today, down from thousands of dollars per gram, against prices near $2,000 a gram.
~59%Share of fed-batch antibody cost of goods that is capital: the sterile plant, not the sugar or the cells.

The answer in one paragraph

Nature grows things cheaply because it does not pay for what a factory must: a sealed, sterile vessel, oxygen pumped into water, heat pumped out, and a purification train that separates one molecule from everything else. Biotechnology has made cells enormously more productive, and that has cut one bill, tank time, by a hundredfold. It has not changed the other two. Feedstock is bounded by chemistry: you cannot make a kilogram of protein from less sugar than the carbon it contains. Purification is bounded by how pure the product must be. The products we already make cheaply by fermentation, ethanol, citric acid, and amino acids, are the ones that escape most of the sterility, oxygen, and purity bills. The frontier is extending that escape to proteins and food.

  • Antibody titers have risen more than a hundredfold since the mid-1980s, to more than 8 g/L in commercial fed-batch today.
  • Antibody cost of goods has fallen from thousands of dollars a gram to tens to hundreds; the bottleneck has moved into purification and capital.
  • Fermented commodities such as lysine and citric acid sell for about $1–2 a kilogram, within a few times the price of the sugar they start from.
  • Between them lies a gap of about five orders of magnitude. Cultivated meat and fermented food protein need to land at its bottom.

Measured results, derived quantities, projections, targets, and editorial inference are identified by context. Company targets are never treated as operating performance.

Part I: The price ladder

Fermentation is already cheap, for some things

The same technique, a microbe or cell in a tank, makes products that cost from under a dollar to tens of thousands of dollars a kilogram. What separates them is not the biology; it is what the process has to pay for.

Figure 2 · The price ladder

What a kilogram costs, from antibody to grain

What a kilogram costs, from antibody to grainOn a logarithmic scale, antibody manufacturing costs about $50,000 per kilogram, lysine about $1.40, citric acid about $1, fuel ethanol about $0.60, raw sugar about $0.40, and corn grain about $0.17.$0.1$1$10$100$1k$10k$100kAntibodyLysineCitric acidFuel ethanolRaw sugarCorn grain123456US dollars per kilogram (log scale)
Antibody · $50k

Cost of goods, not price: reviews put today's antibody manufacturing at tens to hundreds of dollars per gram, plotted at $50 a gram. Mammalian cells, sterile fed-batch, 5–8 g/L, and multi-step chromatography. Selling prices are far higher, near $2,000 a gram.

Antibody is a cost-of-goods estimate from industry reviews; the others are approximate 2025 market prices, rounded, and include each seller's margin. The gap between antibody and the fermented commodities is five orders of magnitude, and it is almost empty: that is where cultivated meat and fermented food protein need to land, at a few dollars a kilogram.
Part II: The physical stack

Six layers between a cell and a kilogram

A production organism is only the first layer. Most of the cost of a bio-manufactured product is set by the equipment that keeps it alive, fed, uncontaminated, and separated from everything else.

01

Strain

A cell line or microbe engineered to turn feedstock into product: CHO cells for antibodies, bacteria for amino acids, yeast for ethanol and food proteins.

Measure
Titer · yield · specific productivity
Failure boundary
A strain that performs in a 2 L flask but loses productivity or stability over the generations a production tank requires.
Where the frontier moves

DNA synthesis, genome editing, and automated screening have made new strains fast to build. This is no longer usually the slowest layer.

02

Feedstock and media

Sugar for microbes; for animal cells, a chemically defined broth of glucose, amino acids, vitamins, salts, and sometimes growth factors.

Measure
$/kg product · carbon yield
Failure boundary
Pharmaceutical-grade media priced for grams, not tonnes. Animal-cell media has never been made at food scale.
Where the frontier moves

Plant hydrolysates and food-grade amino acids instead of pharmaceutical inputs; recombinant growth factors made cheaply by microbes.

03

Sterile vessel

A pressure-rated steel tank or single-use bag, steam-sterilised, sealed, with every valve, probe, and gas line kept free of contaminants for days or weeks.

Measure
$/litre installed · batch failure rate
Failure boundary
One contaminating microbe can outgrow the product organism and lose the whole batch.
Where the frontier moves

Robust hosts that tolerate open or semi-sterile operation: acid-, salt-, or heat-loving organisms that other microbes cannot survive with.

04

Oxygen and heat

Aerobic cells need oxygen dissolved in water, where it is sparingly soluble, and they release heat in proportion to the oxygen they consume.

Measure
Oxygen transfer rate · W/L removed
Failure boundary
At large volume, mixing time and gas transfer lag behind demand; cells in part of the tank starve or overheat, and bubbles damage animal cells.
Where the frontier moves

Better spargers and reactor geometry, anaerobic or low-oxygen product pathways, gas fermentation, and continuous processes that run smaller tanks harder.

05

Harvest and purification

Separating product from cells, broth, host proteins, DNA, and viruses: centrifugation, filtration, chromatography, crystallisation, or distillation.

Measure
% recovered · $/kg purified
Failure boundary
For injectable proteins, each step loses product and costs resin, buffer, and time; this is now where most antibody cost sits.
Where the frontier moves

Continuous chromatography, cheaper affinity ligands, and products (food, feed, materials) that do not need injectable purity.

06

Quality and release

Proving each lot is what it says it is, at the purity, potency, and safety its use requires.

Measure
Days to release · lots rejected
Failure boundary
Release testing and documentation take fixed time whatever the tank's output.
Where the frontier moves

In-line analytics and real-time release, and regulators that accept them.

Part III: The floor

Three bills, and only one of them shrinks with titer

Cost per kilogram is feedstock divided by yield, plus tank time divided by titer, plus purification, all divided by what purification recovers. Better cells shrink the middle term. The first is bounded by chemistry and the last by purity.

feedstock ÷ yield+tank time ÷ titer+purification=cost per kilogram

Carbon sets the feedstock floor. Glucose is 40% carbon by mass; protein is roughly half carbon. Even if every carbon atom ended up in product, a gram of protein would need about 1.3 grams of glucose (Derived). Cells also burn sugar for energy, so real yields are lower. At sugar near $0.40 a kilogram the feedstock floor for fermented protein is on the order of a dollar a kilogram: cheap for a drug, significant for food.

Oxygen and heat set the tank-time floor for aerobic processes. Oxygen dissolves in water at only a few milligrams per litre, so it must be transferred continuously; industrial fermenters are designed for transfer rates of the order of a few hundred millimoles per litre per hour. Aerobic metabolism releases roughly 460 kJ of heat per mole of oxygen consumed, so a tank running at 300 mmol/L/h must remove close to 40 watts per litre (Derived). A 200 m³ fermenter at that rate rejects several megawatts of heat. Productivity per litre is capped by how fast the tank can breathe and cool, which is why ethanol, an anaerobic process, is the cheapest fermentation product at scale.

Purity sets the purification floor. An injectable antibody must be separated from host-cell proteins, DNA, and potential viruses to parts-per-million levels. Feed-grade lysine can be dried with much of its broth. Most of the five orders of magnitude in Figure 2 is the difference between those two standards.

Figure 3 · Interactive model

What sets the cost of a kilogram grown in a tank?

Every fermented product pays three bills: tank time, which falls as titer rises and batches shorten; feedstock, which is fixed by chemistry; and purification. Move titer and see which bill starts to dominate.

Antibody, CHO fed-batch$50,070/kg product

That is $50 a gram.

Tank time (vessel, sterility, oxygen, cooling)
$23,333 · 47%
Feedstock (sugar or media ÷ yield)
$133 · 0%
Purification
$26,603 · 53%
Feedstock floor alone
$133

Presets are illustrative and calibrated only to the order of magnitude of the prices in Figure 2. They are not audited plant data. The antibody preset lands near $50 a gram and the ethanol preset near $0.75 a kilogram before co-product credits such as distillers' grains.

Calculation and boundaries

Tank time per kg = (cost of one litre of installed, sterile, aerated, cooled tank for one day) × batch days × (1,000 ÷ titer in g/L). Feedstock per kg = feedstock price ÷ product yield. Total = (tank + feedstock + purification) ÷ purification recovery. Tank cost bundles capital recovery, utilities, labour, and quality systems, which is why it spans four orders of magnitude between a pharmaceutical suite and an ethanol plant. Excludes co-product credits, turnaround time between batches, failed batches, and margins.

An editorial cost frame, not a techno-economic model. Its purpose is to show that raising titer only cuts the tank-time bill; the feedstock bill is a floor set by stoichiometry, and purification scales with how pure the product must be.
Part IV: The bottleneck shift

From building the cell to building the tank

For forty years the hard part was getting cells to make enough. That problem was largely solved. The binding constraints are now sterility, oxygen, heat, purification, and the capital they require.

Strains became cheap

Reading, writing, and editing DNA made building a production organism a matter of weeks. Titer rose a hundredfold, mostly through media and process control.

Upstream stopped dominating

As titer climbed past a few grams per litre, reviews describe the production bottleneck moving into downstream purification, which can account for more than half of antibody manufacturing cost.

Capital became the bill

In fed-batch antibody plants about 59% of cost of goods is capital: a sterile, validated plant costs the same whether the cells are productive or not.

Food needs a different machine

For products worth a few dollars a kilogram, tank time must fall by orders of magnitude, not percentages. That is a reactor-design and sterility problem, not a genetics problem.

What a field gets for free

A cornfield is a bioreactor that is never sterilised, powered by sunlight rather than electricity, aerated by the atmosphere, cooled by evaporation, and harvested without purification. Its productivity per unit of volume is tiny compared with a fermenter; its cost per unit of output is tiny too. Nature pays with land and time instead of steel and energy, and it accepts a mixture, grain, stalk, and root, rather than one molecule at one purity.

Industry has partial copies of each of those tricks. Ethanol skips oxygen transfer and tolerates imperfect sterility because yeast at high sugar and alcohol concentrations outcompetes most contaminants. Citric acid is made by a fungus at a pH few competitors can tolerate. Research groups have run engineered salt-loving bacteria in open, unsterilised fermentations to make bioplastics, and gas fermentation plants turn steel-mill off-gas into ethanol at commercial scale. Egg-based influenza vaccine production uses biology's own sealed vessel. Each of these avoids a layer of the stack rather than optimising it.

Cultivated meat is the hardest test. Humbird's 2021 techno-economic analysis concluded that low growth rate, metabolic inefficiency, CO₂ inhibition, and bubble damage limit practical bioreactor size and cell density, that contamination safeguards make the equipment expensive, and that suitable amino acids and growth factors are not made at food scale. The Good Food Institute disputes several of its cost assumptions, including equipment prices and installation factors. Neither side disputes the structure: animal cells in a sterile, aerated tank carry every bill in the equation, and food prices leave no room for any of them.

The optimistic view, with conditions

The fermented commodity class widens

If robust hosts, food-grade media, and simpler reactors let proteins and fats be made the way lysine and citric acid already are, a new class of products could reach a few dollars a kilogram without needing nature's land.

Now

Cheaper biologics

Higher titer and continuous purification push antibody cost of goods toward low tens of dollars a gram, which matters for global access more than for margins.

Next

Food ingredients by precision fermentation

Microbial production of specific proteins and fats in large, aerobic tanks with food-grade purification: the lysine playbook applied to higher-value molecules.

Structural

Open, robust bioprocessing

Hosts that tolerate unsterile operation, gas feedstocks, and continuous processing that together cut the tank-time bill by orders of magnitude.

Where each measure stands

View the scorecard
MeasureRecord through September 2026What the optimistic case needs
Antibody titer, commercial>8 g/LRising slowly; the cost now sits elsewhere
Antibody cost of goods$10s–100s per gramLow tens of dollars per gram for global-access biologics
Aerobic bulk fermentationAbout $1–2/kg (lysine, citric acid)The same cost class for proteins and fats
Animal cells as foodNot demonstrated at commodity scaleA few dollars per kilogram, without pharmaceutical media or sterility
Non-sterile productionAnaerobic ethanol; acid-tolerant citric acidEngineered robust hosts making higher-value products in open tanks

Baselines are reported results or approximate market prices. Targets are editorial benchmarks, not forecasts.

What cheap biomanufacturing actually needs

  1. Cheaper tank timeReactors that cost less per litre-day, run continuously, and do not need pharmaceutical sterility for food and materials.
  2. Oxygen-efficient productsPathways and hosts that need less oxygen per kilogram, or none, so heat and gas transfer stop capping productivity.
  3. Food-grade inputs at scaleMedia and growth factors made at tonne scale and priced like feed, not like reagents.
  4. Purity matched to usePurification designed for what the product must be, not inherited from injectable drugs.
  5. UtilisationPlants that run full, because capital, not sugar, is most of the bill.

Sources, method, and boundaries

The titer curve uses ranges from industry reviews and one development-scale measurement; it shows the shape of the curve rather than audited plant averages. The price ladder mixes one cost-of-goods estimate with approximate 2025 market prices, which include margin. The cost equation and calculator are editorial frames calibrated to order of magnitude only. Heat and carbon figures are derived from standard stoichiometry and are marked Derived.

Titer
Concentration of product in the culture at harvest, in grams per litre.
Fed-batch
A culture fed nutrients during a run of one to three weeks and harvested once.
Cost of goods
The manufacturer's cost to produce a unit of product, including capital recovery, before margin.
Downstream processing
Everything after the tank: harvest, purification, formulation.